Clinical Trial Update: The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKU

View source ↗

Summary

Clinical trial update indicating the study evaluating sapropterin dihydrochloride supplementation for in vivo redox status in classical phenylketonuria has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: Stanford University | Conditions: Classical Phenylketonuria(PKU) | Status: WITHDRAWN